Traders should monitor trading volume and institutional ownership trends following the uplisting, as enhanced visibility could lead to modest increases in liquidity over time. However, no immediate fundamental change in financial performance should be expected.
Price Chart
Executive Summary
Tonix Pharmaceuticals has been approved to uplist its common stock from the Nasdaq Capital Market to the Nasdaq Global Select Market, effective March 3, 2026, under the same ticker symbol TNXP. This move reflects compliance with higher financial and governance standards and may improve liquidity and institutional investor visibility.
Key Facts
- Tonix Pharmaceuticals (TNXP) uplisted from Nasdaq Capital Market to Nasdaq Global Select Market effective March 3, 2026.
- The uplisting reflects compliance with stricter financial and corporate governance requirements.
- Trading continues under the same ticker symbol 'TNXP'.
- The company believes the move may enhance investor visibility, liquidity, and market recognition.
- No financial figures such as revenue or EPS changes were disclosed in connection with the uplisting.
Financial Impact
No direct financial impact reported; potential indirect benefits include improved liquidity and investor access.
Risk Factors
- Uplisting does not guarantee increased trading volume or share price appreciation.
- Company remains small-cap ($170M market cap), which may limit appeal to large institutional investors despite the improved listing tier.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3248122 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | Press Release | $5.73 | awaiting T+20 | — | $5.30 (−7.50%) |
Oct 15, 2026 12d ago | 8-K | $6.42 | awaiting T+20 | — | $5.30 (−17.45%) |
Oct 2, 2026 24d ago | 8-K | $8.07 | awaiting T+20 | — | $5.30 (+34.32%) |
Sep 22, 2026 5w ago | 8-K | $10.59 $5.78 | ▼ −45.42% | ▼ −44.86% | $5.30 (−49.95%) |
Sep 8, 2026 7w ago | 8-K | $13.16 $7.70 | ▼ −41.49% | ▼ −43.46% | $5.30 (−59.73%) |
Aug 10, 2026 11w ago | 8-K | $12.59 $13.16 | ▲ +4.53% | ▲ +5.44% | $5.30 (−57.90%) |
Aug 10, 2026 11w ago | Press Release | $12.59 $13.16 | ▲ +4.53% | ▲ +5.44% | $5.30 (−57.90%) |
Aug 3, 2026 12w ago | 8-K | $10.67 $14.10 | ▲ +32.15% | ▲ +30.91% | $5.30 (−50.33%) |
Jul 27, 2026 13w ago | Press Release | $10.37 $12.45 | ▲ +20.06% | ▲ +16.76% | $5.30 (−48.89%) |
Jul 13, 2026 15w ago | 8-K | $11.71 $12.59 | ▲ +7.56% | ▲ +4.38% | $5.30 (−54.72%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers